A multicentre phase III randomised controlled study of Theratope vaccine for metastatic breast cancer
Completed
- Conditions
- BreastCancer
- Registration Number
- ISRCTN91516565
- Lead Sponsor
- K Co-ordinating Committee for Cancer Research (UKCCCR)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 0
Inclusion Criteria
1. Must have received 4-8 cycles or 12-24 weeks duration of first line chemotherapy for metastatic disease
2. Has either no evidence of disease of non-progressive disease following first line chemotherapy or stable disease
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration